What’s New in Ontosight® Terminal 1.1 A Complete Guide toRead More
What’s New in Ontosight® Terminal 1.1
Archives: News
Google für die Gesundheitsbranche
Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen aus dem Internet und Datenbanken aufspürt und aufbereitet. Gunjan Bhardwaj (35) war auf dem besten Wege, das auskömmliche Leben eines aufstrebenden Unternehmensberaters zu führen. Arbeit und Gehalt bei Ernst & Young stimmten, das Betriebsklima war …
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years to be approved. High costs, 90% failure rate, and the lengthy timeline have all contributed to Pharma’s incompetence. The technique of using multiple compounds in the trial phase to increase the chances of drug approval …
How can AI be leveraged for Clinical Trial Prediction? Read More »
Innoplexus, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine learning and blockchain technologies, has received series C funding in the sum of double-digit millions. The round was co-led by FinLab EOS VC Fund, a venture capital fund backed by both Block.one, the publisher of …
Innoplexus’ Clinical Trial Prediction Engine predicted Aducanumab Failure
Frankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to the tune of $18Bn for investors after the company ended a phase III trial of its Alzheimer’s drug, Aducanumab. The trial was running since June 2015 and was predicted by Goldman Sachs in Aug 2017 …
Innoplexus’ Clinical Trial Prediction Engine predicted Aducanumab Failure Read More »
An AI Firm Wants to Predicts Costly Pharma Flops
Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales of about $3.7 billion by 2023. A German artificial-intelligence firm had come to a different conclusion. Innoplexus AG, a closely held company based in the outskirts of Frankfurt, uses an algorithm to analyze pharma companies’ …
An AI Firm Wants to Predicts Costly Pharma Flops Read More »
Finger on the Pulse: GTC Spotlights Startups Propelling AI in Healthcare
It can be hard to stay healthy in a convention center filled with thousands of people — unless, of course, you’re at the GPU Technology Conference, where healthcare players big and small are showcasing the latest innovations in AI and medicine. GTC 2019, held last week in Silicon Valley, featured more than 40 healthcare sessions, …
Finger on the Pulse: GTC Spotlights Startups Propelling AI in Healthcare Read More »
Pharma & Healthcare Analytics Is Going To Be The Next Big Thing In India
The Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by the Federation of Indian Chamber of Commerce and Industries (FICCI), “India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 …
Pharma & Healthcare Analytics Is Going To Be The Next Big Thing In India Read More »
Innoplexus: Real-Time Data Analytics to Empower Decision Making
The evolution of artificial intelligence (AI) has taken the healthcare sector by a storm promising enhanced data analytics for effective decision making. However, most of the AI tools have failed to deliver practical solutions in terms of data analytics particularly in healthcare, where decoding the value of data is becoming ever important. Lawrence Ganti, CEO …
Innoplexus: Real-Time Data Analytics to Empower Decision Making Read More »
8 Startups Ahead of the Pulse in Healthcare
AI enabled healthcare is swiftly becoming today’s reality, fueled by innovative startups in the field. These startups are leveraging GPUs to develop AI applications that can analyze large amounts of data, identify patterns, and inform a diagnosis. At this year’s GPU Technology Conference (GTC), which takes place from March 17 to March 21 in San …
